Email Jacob Rosenfeld

NASDAQ:AMGN Long Term Investor Alert: Lawsuit Against Directors of Amgen, Inc. Filed

An investor in shares of Amgen, Inc. (NASDAQ:AMGN) filed a lawsuit against directors of Amgen, Inc over alleged breaches of fiduciary duties in connection certain statements.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy

 
ReleaseWire - 500 Error

Unfortunately, something has gone wrong.

We're unable to fulfill your request. Rest assured we have been notified and are looking into the issue. Please refresh your browser. If the error continues, please contact our support team.